GSK links up with US university on genome research
GlaxoSmithKline is launching a rare partnership with an American university through which the UK drugmaker will fund more than 20 scientists at a new laboratory focused on human genome research.
The pharma group is linking up with the University of California to deploy cutting-edge gene editing technology invented by professors at the campus in an attempt to find the next generation of blockbuster drugs.
Under a five-year agreement announced on Thursday, GSK and the university said they will jointly establish the Laboratory for Genomics Research, “to unravel mysteries of the human genome.”
